Zoetis Inc. vs Jamjoom Pharmaceuticals Factory Co.
A head-to-head of Zoetis Inc. (ZTS) and Jamjoom Pharmaceuticals Factory Co. (4015) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | ZTS | 4015 |
|---|---|---|
| Market Cap | $32.10B | 11.05B SAR |
| P/E (TTM) | 12.70 | 22.16 |
| Forward P/E | 10.36 | — |
| P/S | 3.64 | 7.25 |
| P/B | 11.89 | 5.95 |
| EV/EBITDA | 10.32 | 20.41 |
| Dividend Yield | 2.31% | 253.00% |
| Profit Margin | 27.79% | 31.16% |
| Gross Margin | 71.84% | 62.56% |
| Operating Margin | 38.00% | 31.82% |
| Revenue Growth (YoY) | +2.91% | +5.21% |
| FCF Yield | 6.44% | 2.33% |
| Debt / Equity | 279.77 | 1.20 |
| Current Ratio | 3.15 | 4.94 |
Which is better: Zoetis Inc. or Jamjoom Pharmaceuticals Factory Co.?
- ✓Larger by market cap: Zoetis Inc.
- ✓Cheaper valuation (lower P/E): Zoetis Inc.
- ✓Higher dividend yield: Jamjoom Pharmaceuticals Factory Co.
- ✓More profitable (net margin): Jamjoom Pharmaceuticals Factory Co.
- ✓Faster revenue growth: Jamjoom Pharmaceuticals Factory Co.
- ✓Higher free-cash-flow yield: Zoetis Inc.
Very close — each leads on 6 metrics.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.